Argatroban/fondaparinux sodium/AZD-1222Immune-mediated thrombosis, thrombocytopenia and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1904卷 / 1期

关键词：

D O I：

10.1007/s40278-022-14010-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：78 / 78

相关论文

共 50 条

[31] AZD-1222Thrombosis thrombocytopenia syndrome: case report
Reactions Weekly, 2023, 1946 (1) : 103 - 103
[32] Azd-1222Thrombosis with thrombocytopenia syndrome: case report
Reactions Weekly, 2023, 1986 (1) : 90 - 90
[33] AZD-1222Thrombosis with thrombocytopenia syndrome: case report
Reactions Weekly, 2022, 1901 (1) : 118 - 118
[34] AZD-1222Thrombosis syndrome with thrombocytopenia: case report
Reactions Weekly, 2023, 1945 (1) : 117 - 117
[35] AZD-1222Thrombocytopenia thrombosis syndrome: case report
Reactions Weekly, 2022, 1887 (1) : 131 - 131
[36] Argatroban/heparinHeparin-induced thrombocytopenia and thrombosis and lack of efficacy: case report
Reactions Weekly, 2022, 1912 (1) : 90 - 90
[37] Azd-1222/immune-globulinQuadriparesis and lack of efficacy: case report
Reactions Weekly, 2022, 1923 (1) : 94 - 94
[38] Azd-1222Lack of efficacy: case report
Reactions Weekly, 2023, 1954 (1) : 99 - 99
[39] AZD-1222/immune globulinVarious toxicities and lack of efficacy: case report
Reactions Weekly, 2021, 1885 (1) : 101 - 101
[40] AZD-1222Lack of efficacy: case report
Reactions Weekly, 2023, 1939 (1) : 101 - 101

← 1 2 3 4 5 →